![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/9/2019 14:25 | It was was up when they re listed , Cant recall the initial name now !!! LR2 might be able to elaborate on that score | ![]() botak54 | |
27/9/2019 13:56 | To whom it may concern... I have been accused of having the 'Botak54' alias by Hazl. This is Hazl's most recent lie about me. He is an annoying little oik and I reserve the right to defend myself from his fibs. Stupid boy. Playground behaviour. | ![]() lr2 | |
27/9/2019 13:47 | More ramping here on the hope this will suddenly go up 100% based on no news PmslWill finish red | ![]() jammydodger1 | |
27/9/2019 13:35 | I think they are concentrating on Bleepa though now, as discussed in earlier posts but presumably Texrad is still out there as a possibility. | ![]() hazl | |
27/9/2019 13:32 | For who it may concern...I never tell lies and have never felt the need to do so. It is playground behaviour at best. Moving on.... | ![]() hazl | |
27/9/2019 13:30 | AH THIS PUTS IT BETTER ' TexRAD® is now used across Europe and the Company is looking to expand its existing customer bases in the US and Asia. As outlined in the recent trading update, the Company has initiated plans for regulatory approval of TexRAD® with the US FDA including 510k as medical device and CFR Chapter 21 part 11 compliance for use in clinical trials of drug candidates for FDA marketing approval. Dr Balaji Ganeshan, Global Business Development Director of Feedback Medical Ltd, said: “These recent orders of TexRAD® are further validation of Feedback Medical and our technology. We are taking advantage of our growing reputation to drive new business. These new business wins have resulted from having referrals from current customers and penetrating new country markets. TexRAD® is now being used in a diverse range of research fields which demonstrates the significant potential and applicability of our technology.” see www.fbk.com. | ![]() hazl | |
27/9/2019 13:29 | Pete, Hazl regularly tells lies about me, I do not intend to give him free rein to continue to do so. Suggest you filter me if you dislike seeing me defending myself. I always stated that the IQAI board said they would be able to get FDA approval without TexRAD having the same. I thought that unlikely but am pleased they have done so. After all, when TexRAD next comes in front of the FDA (presumably in the form of TexRAD Lung) they now have precedence they can show as to why FDA approval should be no great obstacle. | ![]() lr2 | |
27/9/2019 13:24 | I thought they had could be wrong...more interested in Bleepa got so much going for it! | ![]() hazl | |
27/9/2019 13:20 | When they do finally get round to applying for FDA Texrad, their job has surely become a little easier. Win win. | petekand | |
27/9/2019 13:20 | I think that it makes it seem more possible now Pete don't you? | ![]() hazl | |
27/9/2019 13:17 | George too of course posts on LSE. | ![]() hazl | |
27/9/2019 13:17 | Perhaps also Fdbk should have followed up with a RNS themselves to highlight Stonechecker's approval explaining how Texrad fits in. Missed opportunity I think. | petekand | |
27/9/2019 13:10 | I hope Ash comes back too appreciated his posts. Ashtree? | ![]() hazl | |
27/9/2019 13:09 | Thanks for your support Pete appreciated. FDBK's time is now at last I believe! | ![]() hazl | |
27/9/2019 13:07 | I suppose this is good news for Fdbk that Stonechecker has gained FDA approval as we stand to book royalties once sales get underway. Well done Iqai - they deserve the rewards and a big shame that Fdbk which owns Texrad, Stonechecker's underlying technology, have not got a clue or will to go for FDA themselves - yet! LR2 - your analysis of these matters especially Iqai proving to be spectacularly wrong. Perhaps you need to start giving others like Hazl a break. | petekand | |
27/9/2019 13:00 | Quite sad how people here are trying to cash in on another share news ridiculous | ![]() jammydodger1 | |
27/9/2019 12:46 | There is an FDBK twitter group now started for sensible posters of which there are many here but we have been invaded I feel. Tozzer is the admin. Hope to see sensible folk there. Toodle pip. | ![]() coldspring | |
27/9/2019 12:34 | You know I have David stop being a naughty boy. | tidy 2 | |
27/9/2019 12:32 | Have you ever held a stock more than 1 day tidy/degsy ? | ![]() dave4545 | |
27/9/2019 12:20 | Dave I hope you wear slips-ons | tidy 2 | |
27/9/2019 12:08 | So you have newtothisgame pumping this hard with all his twitter accounts and believe me he is using lots. And a few more regular pump and dump accounts on the go, good news for those who might want to take advantage of the spike and reduce or sell then buy them back when they all sell out. cappick has done this on ovb and hng this week, very effective using 10 twitter accounts on the go pumping away, exhausting but clearly works. Nothing against FDBK btw I like it too, just intraday comments | ![]() dave4545 | |
27/9/2019 11:56 | A great morning meeting people at Princess Alexandra Hospital today. Amazing staff. Love #OurNHS.hTTps://twit | tidy 2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions